« Back
Immatics presenting at Cell & Gene Therapy - Manufacturing & Commercialization 2021
Sep 20 - Sep 21, 2021
Join Immatics at the Cell, Gene & Immunotherapy Event for Ground-Breaking Bioprocessing, Manufacturing and Supply Chain Strategies
Tuesday, September 21, 4:00pm - 4:30pm EST
Session: Gene Edited Ex Vivo Cell Therapy
Presentation Manufacturing process optimization during early- and late-stage development
- Development of TCR-engineered T cell therapies against novel targets for solid tumors
- Case study for optimized vein-to-vein time
- Outlook for closed system automated for late-stage development
Presenter: Ali Mohamed, VP CMC Immatics
Tuesday, September 21, 4:30pm - 5:00pm EST
Session: Gene Edited Ex Vivo Cell Therapy
Panel Discussion: Let’s Settle the Debate – Can Auto and Allo Therapies Co-Exist
Use this opportunity to ask your expert speakers your burning questions
Speakers:
John A. Rowley, Founder & CFO RoosterBio Inc.
Armon Sharei, CFO & Founder SQZ Biotechnologies, USA
Cenk Sumen, CTO Stemson Therapeutics
Ali Mohamed, VP CMC Immatics
We are looking forward to (e-)meeting you!
For more information please visit the event's website: Cell & Gene Therapy Manufacturing & Commercialization US | Cell and gene therapy conference
Location